Guangdong Provincial People's Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1946-01-01
- Employees
- -
- Market Cap
- -
MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer
Completed
- Conditions
- First Posted Date
- 2021-06-01
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 301
- Registration Number
- NCT04909554
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2023-03-17
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Registration Number
- NCT04894682
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-05-07
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 31
- Registration Number
- NCT04877821
- Locations
- 🇨🇳
NeoSACT, Guangzhou, Guangdong, China
The Effect of HIIT, MICT in Patients With Myocardial Infarction
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2021-12-09
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT04863677
- Locations
- 🇨🇳
Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 57
- Registration Number
- NCT04858516
Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study)
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 774
- Registration Number
- NCT04858529
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Observational Study for Patients With Hypertrophic Cardiomyopathy
Recruiting
- Conditions
- First Posted Date
- 2021-04-20
- Last Posted Date
- 2021-04-20
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT04851652
- Locations
- 🇨🇳
Guangdong cardiovascular institute, Guangzhou, Guangdong, China
Observational Study for Patients With Dilated Cardiomyopathy
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT04837612
- Locations
- 🇨🇳
Guangdong cardiovascular institute, Guangzhou, Guangdong, China
A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer
Completed
- Conditions
- First Posted Date
- 2021-03-30
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 155
- Registration Number
- NCT04822103
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
🇨🇳Shantou Central Hospital, Shantou, Guangdong, China
Early Nutritional Intervention in NPC Patients Undergoing Concurrent Chemoradiotherapy
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 272
- Registration Number
- NCT04810936
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
© Copyright 2024. All Rights Reserved by MedPath